Ingrid Luyten SRL
Ingrid Luyten reported total assets of 100,696 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Jun 2026).
The score of Ingrid Luyten shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -13 % Total assets -14 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ingrid Luyten's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Jun 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 03 Jul 2024
- Year ended 31 Dec 2022filed on 17 Jul 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
Ingrid Luyten's financial analysis
- Solvency96.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ingrid Luyten
Ingrid Luyten's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0627.936.923
- VAT number
- BE0627936923
- Peppol
- Registered · 0208:0627936923 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Apr 2015
- Registered office
- 2300 Turnhout
- Latest accounts
- 2025 · filed on 26 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Ingrid Luyten (SRL) has been based in Turnhout since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 3,997 € and equity of 96,900 €; its revenue is not published. Its solvency stands at 96.2%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Ingrid Luyten
Companies in the same business, of comparable size and area, outside its group.
- Apotheek de Linde Retail sale of pharmaceutical products Hoeilaart · balance sheet 99,970 €
- Mencina Retail sale of pharmaceutical products Antwerp · balance sheet 99,620 €
- Philexis Retail sale of pharmaceutical products Kraainem · balance sheet 101,847 €
- Societe Pharmaceutique de Gestion Retail sale of pharmaceutical products Ixelles · balance sheet 86,711 €
- Stelieco Retail sale of pharmaceutical products Brasschaat · balance sheet 96,802 €
- APVL Retail sale of pharmaceutical products Bornem · balance sheet 96,516 €
- Rechter Apotheke Retail sale of pharmaceutical products Sankt Vith · balance sheet 105,065 €
- Pharmacie Thonon Retail sale of pharmaceutical products Orp-Jauche · balance sheet 101,626 €
Frequently asked questions about Ingrid Luyten
What is the revenue of Ingrid Luyten?
Ingrid Luyten files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ingrid Luyten?
In Belgium, the VAT number is the company number prefixed with BE: BE0627936923 for Ingrid Luyten, if the company is VAT-registered. Its company number (CBE) is 0627.936.923.
Where is the registered office of Ingrid Luyten?
According to the CBE register, the registered office of Ingrid Luyten is in 2300 Turnhout.
What is the equity of Ingrid Luyten?
At the close of the 2025 financial year, the equity of Ingrid Luyten amounts to 96,900 €, a solvency of 96.2% of total assets.
Who manages Ingrid Luyten?
The register lists 1 active mandates at Ingrid Luyten. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ingrid Luyten
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →